News search

This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease

• ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
• ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
  
• The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.

Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)

The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors

The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

CNIC researchers have discovered a new inflammatory control mechanism that paves the way to controlling injury generated during the immune response

CNIC researchers have discovered that the immune system is important not only in the defense against disease but also for the day-to-day function of a healthy organism